223 related articles for article (PubMed ID: 21106306)
1. American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the transperineal permanent brachytherapy of prostate cancer.
Rosenthal SA; Bittner NH; Beyer DC; Demanes DJ; Goldsmith BJ; Horwitz EM; Ibbott GS; Lee WR; Nag S; Suh WW; Potters L; ;
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):335-41. PubMed ID: 21106306
[TBL] [Abstract][Full Text] [Related]
2. The American College of Radiology and the American Brachytherapy Society practice parameter for transperineal permanent brachytherapy of prostate cancer.
Bittner NH; Orio PF; Merrick GS; Prestidge BR; Hartford AC; Rosenthal SA
Brachytherapy; 2017; 16(1):59-67. PubMed ID: 28109632
[TBL] [Abstract][Full Text] [Related]
3. American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of high-dose-rate brachytherapy.
Erickson BA; Demanes DJ; Ibbott GS; Hayes JK; Hsu IC; Morris DE; Rabinovitch RA; Tward JD; Rosenthal SA
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):641-9. PubMed ID: 21106308
[TBL] [Abstract][Full Text] [Related]
4. ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer.
Bittner NHJ; Cox BW; Davis B; King M; Lawton CAF; Merrick GS; Orio P; Ouhib Z; Rossi P; Showalter T; Small W; Schechter NR
Am J Clin Oncol; 2022 Jun; 45(6):249-257. PubMed ID: 35588224
[TBL] [Abstract][Full Text] [Related]
5. American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Stereotactic Radiosurgery (SRS).
Seung SK; Larson DA; Galvin JM; Mehta MP; Potters L; Schultz CJ; Yajnik SV; Hartford AC; Rosenthal SA
Am J Clin Oncol; 2013 Jun; 36(3):310-5. PubMed ID: 23681017
[TBL] [Abstract][Full Text] [Related]
6. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT).
Potters L; Gaspar LE; Kavanagh B; Galvin JM; Hartford AC; Hevezi JM; Kupelian PA; Mohiden N; Samuels MA; Timmerman R; Tripuraneni P; Vlachaki MT; Xing L; Rosenthal SA; ;
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):319-25. PubMed ID: 20117284
[No Abstract] [Full Text] [Related]
7. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy.
Potters L; Kavanagh B; Galvin JM; Hevezi JM; Janjan NA; Larson DA; Mehta MP; Ryu S; Steinberg M; Timmerman R; Welsh JS; Rosenthal SA; ;
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):326-32. PubMed ID: 20117285
[No Abstract] [Full Text] [Related]
8. American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) practice guideline for the performance of total body irradiation (TBI).
Wolden SL; Rabinovitch RA; Bittner NH; Galvin JM; Giap HB; Schomberg PJ; Rosenthal SA; ;
Am J Clin Oncol; 2013 Feb; 36(1):97-101. PubMed ID: 23334484
[TBL] [Abstract][Full Text] [Related]
9. American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for Intensity-modulated Radiation Therapy (IMRT).
Hartford AC; Galvin JM; Beyer DC; Eichler TJ; Ibbott GS; Kavanagh B; Schultz CJ; Rosenthal SA; ;
Am J Clin Oncol; 2012 Dec; 35(6):612-7. PubMed ID: 23165357
[TBL] [Abstract][Full Text] [Related]
10. ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer.
Davis BJ; Taira AV; Nguyen PL; Assimos DG; D'Amico AV; Gottschalk AR; Gustafson GS; Keole SR; Liauw SL; Lloyd S; McLaughlin PW; Movsas B; Prestidge BR; Showalter TN; Vapiwala N
Brachytherapy; 2017; 16(2):266-276. PubMed ID: 27964905
[TBL] [Abstract][Full Text] [Related]
11. The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assurance.
Frank SJ; Mourtada F; Crook J; Orio PF; Stock RG; Petereit DG; Rossi PJ; Cox BW; Tang C; Kudchadker RJ; Bruno T; Ma J; Sanders J; Keyes M
Brachytherapy; 2020; 19(6):787-793. PubMed ID: 33132070
[TBL] [Abstract][Full Text] [Related]
12. ACR-ABS-ASTRO practice parameter for the performance of radionuclide-based high-dose-rate brachytherapy.
Harkenrider MM; Albuquerque K; Brown D; Kamrava M; King M; Mourtada F; Orio P; Patel R; Price M; Rassiah P; Solanki AA; Small W; Schechter NR
Brachytherapy; 2021; 20(6):1071-1082. PubMed ID: 34588143
[TBL] [Abstract][Full Text] [Related]
13. ACR-ABS-ASTRO Practice Parameter for the Performance of Low-Dose-Rate Brachytherapy.
Woodhouse KD; Devlin PM; Kollmeier M; Lin LL; Orio P; Ouhib Z; Song D; Viswanathan AN; Watanabe Y; Yu Y; Small W; Schechter NR
Am J Clin Oncol; 2022 Jun; 45(6):243-248. PubMed ID: 35485607
[TBL] [Abstract][Full Text] [Related]
14. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer.
Nag S; Beyer D; Friedland J; Grimm P; Nath R
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):789-99. PubMed ID: 10386635
[TBL] [Abstract][Full Text] [Related]
15. American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy.
Park CC; Yom SS; Podgorsak MB; Harris E; Price RA; Bevan A; Pouliot J; Konski AA; Wallner PE;
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):963-72. PubMed ID: 20206016
[TBL] [Abstract][Full Text] [Related]
16. Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer.
Merrick GS; Butler WM; Galbreath RW; Lief JH
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):41-8. PubMed ID: 11516849
[TBL] [Abstract][Full Text] [Related]
17. American Brachytherapy Society Task Group Report: Combination of brachytherapy and external beam radiation for high-risk prostate cancer.
Spratt DE; Soni PD; McLaughlin PW; Merrick GS; Stock RG; Blasko JC; Zelefsky MJ
Brachytherapy; 2017; 16(1):1-12. PubMed ID: 27771243
[TBL] [Abstract][Full Text] [Related]
18. ACR-ABS-ACNM-ASTRO-SIR-SNMMI practice parameter for selective internal radiation therapy or radioembolization for treatment of liver malignancies.
Hong K; Akinwande O; Bodei L; Chamarthy MR; Devlin PM; Elman S; Ganguli S; Kennedy AS; Koo SJ; Ouhib Z; Padia SA; Salem R; Selwyn RG; Yashar CM; Yoo DC; Zaki BI; Hartford AC; Trimmer CK
Brachytherapy; 2021; 20(3):497-511. PubMed ID: 33824051
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate.
Lawton CA; Yan Y; Lee WR; Gillin M; Firat S; Baikadi M; Crook J; Kuettel M; Morton G; Sandler H
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e795-801. PubMed ID: 22330999
[TBL] [Abstract][Full Text] [Related]
20. Contemporary prostate cancer radiation therapy in the United States: Patterns of care and compliance with quality measures.
Lee DJ; Barocas DA; Zhao Z; Huang LC; Koyama T; Resnick MJ; Conwill R; McCollum D; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Penson DF; Hoffman KE
Pract Radiat Oncol; 2018; 8(5):307-316. PubMed ID: 30177030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
